News
Hawaii said on Friday it entered a $700 million settlement with pharmaceutical firm Bristol-Myers Squibb and units of French ...
Bristol-Myers Squibb (BMY) and Sanofi (SNY) resolve Plavix marketing litigation with Hawaii in $700M settlement. Read more ...
Sanofi has scrapped its collaboration with IGM Biosciences, eliminating the biotech’s l | Sanofi has scrapped its ...
After losing its powerhouse partner, IGM Biosciences closed “most” of its labs and offices and initiated a strategic review ...
2d
GlobalData on MSNSanofi exec tells biotechs not to scrimp on clinical trial designIt is vital for biotech companies to run the right clinical trial and not cut costs with trial design or patient recruitment, ...
Hawaii will receive $700 million from pharmaceutical giants Bristol Myers Squibb and Sanofi in a landmark settlement over the blood thinner Plavix, Gov. Josh Green announced today—one of the largest ...
The settlement divides the $700 million payment equally between pharmaceutical giants Bristol Myers Squibb and Sanofi.
Hawaii will receive $700 million in a landmark settlement from pharmaceutical giants Bristol Myers Squibb and Sanofi following more than a decade of litigation over the blood thinner Plavix and its ...
Saudi Society of Dermatology and Sanofi Sign MoU to Advance Dermatological Care in Saudi Arabia ...
Sanofi announced an expansion of its partnership with McLaren Racing. The two companies, alongside United Autosports, are ...
Moody’s Ratings has upgraded the long-term issuer rating and senior unsecured ratings of Sanofi (NASDAQ:SNY) from A1 to Aa3.
HONOLULU (HawaiiNewsNow) - The state of Hawaii has entered into a $700 million settlement agreement with pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results